Profiles on Cardiovascular and Diabetes

Published within

« | 1 | 2 | 3 | 4 | 5 | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

Celgene Corporation

Celgene (or 'the company'), an integrated biopharmaceutical company, is engaged in the research, development and marketing of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The company operates in the US, Europe and Asia Pacific. It is headquartered in Summit, New Jersey, and employed 5,100 people as of December 31, 2013.

Published By MarketLine
07 Oct 2014 $175
Buy
Company Profile
Company Profile

Ipsen S.A.

Ipsen (or 'the group') is a global biopharmaceutical group with products in targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. The group primarily operates in Europe and North America. It is headquartered in Boulogne-Billancourt, France, and employed 4,602 people as of December 31, 2013.

Published By MarketLine
07 Oct 2014 $175
Buy
Company Profile
Company Profile

CJ CheilJedang Corp.

CJ CheilJedang Corp. (CJ CheilJedang or 'the company') is engaged in providing food; bioscience-based products; and feed and livestock products. The company operates in Asia, Australia, the US, Germany and Brazil. It is headquartered in Jung-gu, South Korea.

Published By MarketLine
10 Oct 2014 $175
Buy
Company Profile
Company Profile

Actelion Ltd

Actelion (or 'the company') is a biopharmaceutical company focused on the discovery, development and commercialization of synthetic small-molecule drugs to address high unmet medical needs. It has affiliates in more than 30 countries including the US, Canada, Brazil, Australia, Japan and Switzerland, which provide distribution, sales and marketing services. Actelion has operations in the Americas, Europe and Asia-Pacific. The company is headquartered in Allschwil, Switzerland and employed 2,422 people as

Published By MarketLine
20 Oct 2014 $175
Buy
Company Profile
Company Profile

AstraZeneca PLC

AstraZeneca (or 'the company'), a UK-based global biopharmaceutical company, is engaged in developing, manufacturing and marketing prescription pharmaceuticals in several therapeutic areas. The company operates primarily in the Americas, Europe and Asia. It is headquartered in London, the UK, and employed about 51,500 people as on December 31, 2013.

Published By MarketLine
21 Oct 2014 $175
Buy
Company Profile
Company Profile

Depomed, Inc.

Depomed, Inc. (Depomed or 'the company') is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies. The company primarily operates in the US. Depomed is headquartered in Menlo Park, California, and employed 308 people as of March 14, 2014.

Published By MarketLine
29 Oct 2014 $175
Buy
Company Profile
Company Profile

Merck KGaA

Merck KGaA (or 'the group') is a leading company for high-tech products in the pharmaceutical and chemical sectors. The Merck family holds an approximately 70% interest in the group. Merck KGaA operates in 66 countries across the world. It is headquartered in Darmstadt, Germany, and employed 38,154 people as of December 31, 2013.

Published By MarketLine
29 Oct 2014 $175
Buy
Company Profile
Company Profile

Shire plc

Shire (or 'the company') is a specialty biopharmaceutical company primarily operating in North America and Europe. It is headquartered in Dublin, Republic of Ireland, and employed 5,338 people as of December 31, 2013.

Published By MarketLine
07 Nov 2014 $175
Buy
Company Profile
Company Profile

Biogen Idec, Inc.

Biogen Idec (Biogen or 'the company') is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of therapies in the areas of oncology, neurology and immunology. The company's key products include Tysabri (natalizumab), Avonex (Interferon beta-1a) and Rituxan (rituximab). The company primarily operates in the US and Europe. It is headquartered in Weston, Massachusetts and employed about 6,850 people as of December 31, 2013.

Published By MarketLine
11 Nov 2014 $175
Buy
Company Profile
Company Profile

Isis Pharmaceuticals, Inc.

Isis Pharmaceuticals (Isis or 'the company') uses antisense technology, a drug discovery platform, to discover and develop novel drugs for its product pipeline and also for its partners. The company primarily operates in the US. It is headquartered in Carlsbad, California, and employed 304 people as of February 17, 2014.

Published By MarketLine
04 Dec 2014 $175
Buy

« | 1 | 2 | 3 | 4 | 5 | » »|

No help is available.